Lux Health Tech Acquisition EBIT

Lux Health Tech Acquisition (LUXA) currently reports a EBIT of $-1.1M as of June 2022. That compares with $-1.1M in the prior-year period — down 5.6% year over year. That is above the sector sector average of $-63M. Use the charts on this page to explore Lux Health Tech Acquisition's EBIT history and peer comparisons.

Lux Health Tech Acquisition's EBIT decreased from $-1.1M to $-1.1M — a 5.6% year-over-year decrease (period ending June 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Lux Health Tech Acquisition's EBIT of $-1.1M is higher than the its sector sector average of $-63M. That is roughly 98.2% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Lux Health Tech Acquisition reported $-1.1M in EBIT as of June 2022. That compares with $-1.1M in the prior-year period — down 5.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $-1.1M, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is $-63M. From there, open related valuation or income-statement pages for Lux Health Tech Acquisition, and consider following LUXA for alerts when major investors trade the stock.